🇺🇸 FDA
Patent

US 10278372

Genetically modified cells, tissues, and organs for treating disease

granted A61KA61K31/436A61K31/675

Quick answer

US patent 10278372 (Genetically modified cells, tissues, and organs for treating disease) held by Regents of the University of Minnesota expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/436, A61K31/675, A61K35/12, A61K35/15